Neurovascular alterations in chronic hepatitis C: a case-control study

Neurovascular alterations in chronic hepatitis C: a case-control study

Blog Article

Introduction: Hepatitis C is a major health problem: approximately 170 million people are infected with the hepatitis C virus worldwide.It is unclear whether chronic hepatitis C affects atherosclerosis and whether it can cause endothelial and/or autonomic nervous system (ANS) dysfunction.Materials and methods: From April 2008 through April 2009, we studied 76 patients with biopsyconfirmed chronic hepatitis C and no evidence of cirrhosis, ascites, portal hypertension, encephalopathy, or hepatocellular carcinoma.The age-, sex-, BMI- and cardiovascular risk factor- matched control group comprised 76 healthy, HCV-negative individuals with no evidence of liver, autoimmune, or immunoproliferative diseases and no history of cardiovascular events.

Twenty five of the hepatitis C patients were treatment-naive; the other 51 had been treated with interferon (but only 25 had persistent virological responses).Color Doppler sonography was used to measure the intima-media-thickness (IMT) of the common and internal carotid arteries.Endothelial function was assessed g5210t-p90 in the brachial artery with the flow-mediated-dilatation (FMD) test.The ANS was assessed with the tilt, laying to standing, Valsalva, hand grip, deep breath, and stroop tests.

Results: The case group (mean age 52 + 13 years) had a significantly higher internal carotid IMT (0.86 + 0.3 vs 0.67 + 0.

1 mmfor controls; p = 0.002).Chronic hepatitis C was also associated with an odds ratio for carotid plaque formation (reflected by an IMT > 1.3 mm) of 2.

15.Cases also had significantly reduced FMD in the brachial artery (0.46 + 0.9 vs 0.

76 + 0.7 for controls; p = 0.005) and significantly altered sympathetic and parasympathetic function (p = 0.001 vs controls in the Valsalva, hand grip, deep breath, and stroop tests).

Within the case group, all alterations were more severe in patients with significant viremia.Discussion: Our findings suggest that chronic hepatitis C may be a nonclassic cardiovascular risk factor since it seems to influence the onset of pre-atherosclerotic lesions and to promote atherosclerotic plaque formation in patients with pre-existing increases in carotid IMT.It also seems to cause dysfunctions of the vascular endothelium and ANS.Conclusions: Chronic hepatitis C may increase cardiovascular risk and promote ANS dysfunctions, particularly when patients have experienced treatment 730 sunken lake road failure and have persistent viremia.

These patients may require cardiovascular and neurologic follow-up.